{
    "nct_id": "NCT04042025",
    "official_title": "A Long-term Follow-up Study of Patients in the Clinical Trials for Spinal Muscular Atrophy Receiving AVXS-101",
    "inclusion_criteria": "* Any participant with SMA who received onasemnogene abeparvovec-xioi gene replacement therapy in a Novartis Gene Therapies-sponsored clinical study\n* Participant/parent/legal guardian willing and able to complete the informed consent process and comply with study procedures and visit schedule\nHealthy volunteers allowed",
    "exclusion_criteria": "* Parent/legal guardian unable or unwilling to participate in the long-term follow-up safety study",
    "miscellaneous_criteria": ""
}